Entrar/Registro  
INICIO ENGLISH
 
Cirujano General
   
MENÚ

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor

Directorio






>Revistas >Cirujano General >Año 2011, No. S1


Fuente LM
Manejo de las metástasis hepáticas de origen no colorrectales y no neuroendocrinas
Cir Gen 2011; 33 (S1)

Idioma: Español
Referencias bibliográficas: 26
Paginas: 20-22
Archivo PDF: 167.37 Kb.


Texto completo




FRAGMENTO

El hígado es uno de los órganos más afectados por metástasis de diferentes tumores malignos, pueden observarse éstas entre el 10 y el 23% de todos los tumores. Gracias a los avances en cirugía hepática y quimioterapia, así como métodos ablativos, ha cambiado la actitud frente a la enfermedad metastásica del hígado; de considerar a los pacientes en fase terminal, ahora se piensa en intervenir quirúrgicamente a muchos de ellos debido a la disminución considerable de las tasas de morbilidad y mortalidad de la cirugía hepática.


Palabras clave: Sin palabras Clave


REFERENCIAS

  1. Mondragón SR, Barrera FJL, Dolores VR, et al. Tumores hepáticos, actualidades y manejo. México Editorial Prado, 1er edicion, 2010.

  2. Hemming AW, Sielaff TD, Gallinger S, et al. Hepatic resection of noncolorectal, non-neuroendocrine metastases. Liver Transpl 2000; 6: 97-101.

  3. Bilchik A, Wood T, Allegra D. Radiofrequency ablation of unresectable hepatic malignancies: Lessons learned. The Oncologist 2001; 6: 24-33.

  4. Maksan SM, Lehnert T, Bastert G, et al. Curative liver resection for metastatic breast cancer. Eur J Surg Oncol 2000; 26: 209-12.

  5. Seizner M, Morse MA, Vredenburgh JJ, et al. Liver metastases from breast cancer: long-term survival after curative resection. Surgery 2000; 127: 383-9.

  6. Benevento A, Boni L, Frediani L, et al. Result of liver resection as treatment for metastases from noncolorectal cancer. J Surg Oncol 2000; 74: 24.

  7. Alves A, Adam R, Majno P, et al. Hepatic resection for metastatic renal tumors: is it worthwhile? Ann Surg Oncol 2003; 10: 705-10.

  8. Harrison LE, Brennan MF, Newman E, Fortner JG, Picardo A, Blumgart LH, et al. Hepatic resection for noncolorectal, non-neuroendocrine metastases: a fifteen year experience with ninety-six patients. Surgery 1997; 121: 625-32.

  9. Adam R, Laurent A, Azoulay O, Castaign D, Bismuth H. Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 2000; 232: 777-85.

  10. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318.

  11. Jaeck D, Bachellier P, Nakano H, Oussoult-Zoglou E, Weber JC, Greget M. One or two-stage hepatectomy combined with portal embolization for initially nonresectable colorectal liver metastases. Am J Surg 2003; 185: 221-9.

  12. Yamada H, Katoh H, Kondo S, Okushi-ba S, Morikawa T. Hepatectomy for metastases from non-colorectal and non-neuroendocrine tumor. Anticancer Res 2001; 21: 4159.

  13. Earle SA, Perez EA, Gutierrez JC. Hepatectomy enables prolonged a survival in select patients with isolated non-colorectal liver metastasis. Am Coll Surg 2006; 203: 436-446.

  14. Rivoire M, Elias D, De Cian F, Kaemmerlen P, et al. Multimodality treatment of patients ft with liver metastases from germ cell tumors: the role of surgery. Cancer 1: 92: 578-87.

  15. DeMatteo RP, Shah A, Fong Y, et al. Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 2001; 234: 540-7.

  16. Chi DS, Fong Y, Venkatraman ES, et al. Hepatic resection for metastatic gynecologic carcinomas. Gynecol Oncol 1997; 66: 45-51.

  17. Garduño-Lopez AL, Mondragon-Sanchez R, Herrera-Goepfert R, Bernal-Maldonado. Resection of a liver metastasis from a virilizing steroid cell ovarian tumor. Hepato-Gastroenterol 2002; 49: 657-659.

  18. Shirabe K, Shimada M, Matsumata T, Higas-hi H, Yakeishi Y, Wakiyama S, et al. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepato-gastroenterology 2003; 50: 1560-3.

  19. Rose DM, Essner R, Hughes TM, et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 2001; 136: 950-5.

  20. Hahn TL, Jacobson L, Einhorn LH, et al. Hepatic resection of metastatic testicular carcinoma: a further update. Ann Surg Oncol 1999; 6: 640-4.

  21. Lang H, Karavias DD, Tepetes K, Karatzas T, et al. Liver resection for metastatic non-colorectal non-neuroendocrine hepatic neoplasms. Eur J Surg Oncol 2002; 28: 135-139.

  22. Nussbaum KT, Kaudel P, et al. Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period. Ann Surg 2000; 231: 500-5.

  23. O’Rourke TR, Tekkis P, Ye-ung S, et al. Long-term results of liver resection for noncolorectal, nonneuroendocrine metastases. Annals of Surgical Oncology 2008; 15: 207-218.

  24. Laurent C, Rullier E, Feyler A, Masson B, Saric J. Resection of noncolorectal and non-neuroendocrine liver metastases.

  25. Hemming AW, Sielaff TD, Gallinger S, et al. Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transplantation 2000; 6: 97-101.

  26. Harrison LE, Brennan MF, Newman E, et al. Hepatic resection for noncolorectal noneuroendocrine metastases: A fifteen-year experience with ninety-six patients. Surgery 1997; 121: 625-32.



>Revistas >Cirujano General >Año2011, No. S1
 

· Indice de Publicaciones 
· ligas de Interes 






       
Derechos Resevados 2019